Why Healthcare Providers Are Increasingly Investing in cfDNA-Based Diagnostic Solutions
Developments in genomic research and molecular analysis are creating opportunities for the Cell-Free DNA (cfDNA) Testing Market. The technology enables the examination of DNA fragments found in the bloodstream, supporting investigations into disease-associated genetic changes. Increasing demand for non-invasive prenatal testing and liquid biopsy applications is strengthening interest among...
0 Comments 0 Shares 20 Views 0 Reviews